Acquisition of APIRx slide image

Acquisition of APIRx

For personal use only APIRX Research Collaborations VU Free University of Amsterdam, The Netherlands UNIVERSITY AMSTERDAM Academic research with the Dept. of Neurology on effects of cannabinoids and chewing, in particular pain and spasticity in MS. MedChewTM Rx project. Icahn School of Medicine at Mount Sinai University of Nijmegen, The Netherlands Dept. of Psychiatry - Adolescent drug addiction treatment. UNIVERSITY AT ALBANY State University of New York Glauconix and the Univ. of Albany, New York, USA Cannabinoids and Glaucoma and treatment of Sicca Syndrome projects. Incannex WAGENINGEN UNIVERSITY & RESEARCH University of Wageningen; Gelderse Vallei Hospital The Netherlands All Gl projects - IBS, IBS, Crohn's & UC. UBC THE UNIVERSITY OF BRITISH COLUMBIA Univ. of British Columbia, Canada UDIORUM Dept. of Neurology and Psychiatry - Treatment of Drug Addiction and Psychosis. UNIVERSITÀ DEGLI STUDI DI MILANO University of Milano, Italy Dept. of Gastroenterology. IBS and IBD projects. University of St Andrews University of St. Andrews, UK MS, Neurodegenerative diseases and pain. UNIVERSITÄT SALZBURG University Salzburg, Austria Dept. of Biochemistry - Development of high-potency, conjugated cannabinoids; Gl. XXX Universität Basel Basel University, Switzerland Pain, Drug addiction. UNIVERSITY OF PLYMOUTH University of Plymouth, UK Dept. of Neurology - MS site for MedChewTM Rx projects. UNIVERSIDAD NACIONAL /AUTONOMA DE MEXICO The National Autonomous University of Mexico Dept. of Gastroenterology - IBS study. UNIVERSITY of TASMANIA University of Tasmania, Australia Pain, Drug Addiction. Radboud University Nijmegen University of Nijmegen, The Netherlands Dept. of Infectious Diseases. Cannabinoids and infectious diseases - MRSA, MDRSA. NYU New York University, USA Dept. of Psychiatry - Treatment of alcohol and drug addiction. Mauritskliniek Maurits Clinic, The Netherlands Dermatological indications, (Vitiligo, Atopic Dermatitis, Psoriasis). Shareholder Presentation 11
View entire presentation